Cablivi ইউরোপীয় ইউনিয়ন - আইসল্যান্ডীয় - EMA (European Medicines Agency)

cablivi

ablynx nv - caplacizumab - purpura, segamyndun - blóðþurrðandi lyf - cablivi er ætlað fyrir fullorðnum að upplifa þættinum keypti segamyndun purpura (attp), í tengslum við skiptum plasma og ónæmisbæling.

Besremi ইউরোপীয় ইউনিয়ন - আইসল্যান্ডীয় - EMA (European Medicines Agency)

besremi

aop orphan pharmaceuticals gmbh - ropeginterferon alfa-2b - blóðríki - Ónæmisörvandi, - besremi er ætlað eitt og sér í fullorðnir fyrir meðferð polycythaemia vera án einkenna miltisstækkun.

Arikayce liposomal ইউরোপীয় ইউনিয়ন - আইসল্যান্ডীয় - EMA (European Medicines Agency)

arikayce liposomal

insmed netherlands b.v. - amikacin sulfate - sýkingar í öndunarvegi - sýklalyf fyrir almenn nota, - arikayce liposomal is indicated for the treatment of non-tuberculous mycobacterial (ntm) lung infections caused by mycobacterium avium complex (mac) in adults with limited treatment options who do not have cystic fibrosis.

Amifampridine SERB ইউরোপীয় ইউনিয়ন - আইসল্যান্ডীয় - EMA (European Medicines Agency)

amifampridine serb

serb sa - amifampridine phosphate - lambert-eaton myasthenic syndrome; paraneoplastic syndromes, nervous system; nervous system neoplasms; paraneoplastic syndromes; nervous system diseases; autoimmune diseases of the nervous system; neurodegenerative diseases; neuromuscular diseases; neuromuscular junction diseases; immune system diseases; autoimmune diseases; autoimmune diseases of the nervous system; cancer; neoplasms - Önnur lyf í taugakerfinu - einkenni meðferðar á lambert-eaton vöðvaspennaheilkenni (lems) hjá fullorðnum.

Amvuttra ইউরোপীয় ইউনিয়ন - আইসল্যান্ডীয় - EMA (European Medicines Agency)

amvuttra

alnylam netherlands b.v. - vutrisiran sodium - amyloid neuropathies, familial - Önnur lyf í taugakerfinu - treatment of hereditary transthyretin-mediated amyloidosis (hattr amyloidosis) in adult patients with stage 1 or stage 2 polyneuropathy.